These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19888220)

  • 21. Segmentation of dynamic contrast enhanced magnetic resonance imaging data.
    Nielsen T; Mouridsen K; Maxwell RJ; Stødkilde-Jørgensen H; Østergaard L; Horsman MR
    Acta Oncol; 2008; 47(7):1265-70. PubMed ID: 18661437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic contrast-enhanced magnetic resonance imaging of vascular changes induced by sunitinib in papillary renal cell carcinoma xenograft tumors.
    Hillman GG; Singh-Gupta V; Zhang H; Al-Bashir AK; Katkuri Y; Li M; Yunker CK; Patel AD; Abrams J; Haacke EM
    Neoplasia; 2009 Sep; 11(9):910-20. PubMed ID: 19724685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical evaluation of tumor microvascular response to a novel antiangiogenic/antitumor agent RO0281501 by dynamic contrast-enhanced MRI at 1.5 T.
    Muruganandham M; Lupu M; Dyke JP; Matei C; Linn M; Packman K; Kolinsky K; Higgins B; Koutcher JA
    Mol Cancer Ther; 2006 Aug; 5(8):1950-7. PubMed ID: 16928815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small molecule regulators of postnatal Nkx2.5 cardiomyoblast proliferation and differentiation.
    Chen WP; Wu SM
    J Cell Mol Med; 2012 May; 16(5):961-5. PubMed ID: 22212626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A reference agent model for DCE MRI can be used to quantify the relative vascular permeability of two MRI contrast agents.
    Cárdenas-Rodríguez J; Howison CM; Matsunaga TO; Pagel MD
    Magn Reson Imaging; 2013 Jul; 31(6):900-10. PubMed ID: 23583323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intra-individual comparison of different gadolinium-based contrast agents in the quantitative evaluation of C6 glioma with dynamic contrast-enhanced magnetic resonance imaging.
    Li Y; Liu G; Lou X; Chen Z; Ma L
    Sci China Life Sci; 2017 Jan; 60(1):11-15. PubMed ID: 28078511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DCE and DW-MRI monitoring of vascular disruption following VEGF-Trap treatment of a rat glioma model.
    Hoff BA; Bhojani MS; Rudge J; Chenevert TL; Meyer CR; Galbán S; Johnson TD; Leopold JS; Rehemtulla A; Ross BD; Galbán CJ
    NMR Biomed; 2012 Jul; 25(7):935-42. PubMed ID: 22190279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors.
    Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
    Curr Cancer Drug Targets; 2011 May; 11(4):524-35. PubMed ID: 21395548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved Evaluation of Antivascular Cancer Therapy Using Constrained Tracer-Kinetic Modeling for Multiagent Dynamic Contrast-Enhanced MRI.
    Hectors SJ; Jacobs I; Lok J; Peters J; Bussink J; Hoeben FJ; Keizer HM; Janssen HM; Nicolay K; Schabel MC; Strijkers GJ
    Cancer Res; 2018 Mar; 78(6):1561-1570. PubMed ID: 29317433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macromolecular dynamic contrast-enhanced (DCE)-MRI detects reduced vascular permeability in a prostate cancer bone metastasis model following anti-platelet-derived growth factor receptor (PDGFR) therapy, indicating a drop in vascular endothelial growth factor receptor (VEGFR) activation.
    Dafni H; Kim SJ; Bankson JA; Sankaranarayanapillai M; Ronen SM
    Magn Reson Med; 2008 Oct; 60(4):822-33. PubMed ID: 18816866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apparent Diffusion Coefficient and Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Pancreatic Cancer: Characteristics and Correlation With Histopathologic Parameters.
    Ma W; Li N; Zhao W; Ren J; Wei M; Yang Y; Wang Y; Fu X; Zhang Z; Larson AC; Huan Y
    J Comput Assist Tomogr; 2016; 40(5):709-16. PubMed ID: 27224231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of tumor angiogenesis: dynamic contrast-enhanced MRI with paramagnetic nanoparticles compared with Gd-DTPA in a rabbit Vx-2 tumor model.
    Kassner A; Thornhill RE; Liu F; Winter PM; Caruthers SD; Wickline SA; Lanza GM
    Contrast Media Mol Imaging; 2010; 5(3):155-61. PubMed ID: 20586031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic contrast-enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4.
    Fruytier AC; Magat J; Neveu MA; Karroum O; Bouzin C; Feron O; Jordan B; Cron GO; Gallez B
    NMR Biomed; 2014 Nov; 27(11):1403-12. PubMed ID: 25323069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic contrast-enhanced MRI of vascular changes induced by the VEGF-signalling inhibitor ZD4190 in human tumour xenografts.
    Checkley D; Tessier JJ; Wedge SR; Dukes M; Kendrew J; Curry B; Middleton B; Waterton JC
    Magn Reson Imaging; 2003 Jun; 21(5):475-82. PubMed ID: 12878256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic value of dynamic contrast-enhanced MRI contrast agent transfer constant K
    Dickie BR; Rose CJ; Kershaw LE; Withey SB; Carrington BM; Davidson SE; Hutchison G; West CML
    Br J Cancer; 2017 May; 116(11):1436-1443. PubMed ID: 28449009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Water exchange-minimizing DCE-MRI protocol to detect changes in tumor vascular parameters: effect of bevacizumab/paclitaxel combination therapy.
    Zhu W; Kato Y; Artemov D
    MAGMA; 2014 Apr; 27(2):161-70. PubMed ID: 23807596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-beta signaling.
    Kano MR; Bae Y; Iwata C; Morishita Y; Yashiro M; Oka M; Fujii T; Komuro A; Kiyono K; Kaminishi M; Hirakawa K; Ouchi Y; Nishiyama N; Kataoka K; Miyazono K
    Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3460-5. PubMed ID: 17307870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of Treatment Success after Photodynamic Therapy Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Schreurs TJL; Jacobs I; Nicolay K; Prompers JJ; Strijkers GJ
    Theranostics; 2017; 7(19):4643-4657. PubMed ID: 29187893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of Dynamic Contrast-enhanced and Diffusion-weighted MR Imaging in the Detection of Pathologic Complete Response in Cervical Cancer after Neoadjuvant Therapy: A Retrospective Observational Study.
    Jalaguier-Coudray A; Villard-Mahjoub R; Delouche A; Delarbre B; Lambaudie E; Houvenaeghel G; Minsat M; Tallet A; Sabatier R; Thomassin-Naggara I
    Radiology; 2017 Aug; 284(2):432-442. PubMed ID: 28301309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the DWI and Gd-EOB-DTPA-enhanced MRI on assessing the hepatic ischemia and reperfusion injury after partial hepatectomy.
    Lu Y; Liu P; Fu P; Chen Y; Nan D; Yang X
    Biomed Pharmacother; 2017 Feb; 86():118-126. PubMed ID: 27951418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.